Related Experiment Videos
Pitfalls in the evaluation of prognostic factors
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells.
Prostate cancer and prostatic diseases·2016
Allogeneic SCT in refractory or relapsed adult ALL is effective without prior reinduction chemotherapy.
Bone marrow transplantation·2008
Posttranslational regulation of Neurospora circadian clock by CK1a-dependent phosphorylation.
Cold Spring Harbor symposia on quantitative biology·2008
Nonsecretory primary plasma cell leukemia with good response to thalidomide-based treatment.
International journal of hematology·2007
Dependence of serum erythropoietin level on erythropoiesis in leukemia.
Haematology and blood transfusion·1990
Complications of bone marrow transplantation in Chinese.
Haematology and blood transfusion·1990
High-dose chemotherapy with noncryopreserved autologous bone marrow transplantation for acute myeloid leukemia in first complete remission.
Haematology and blood transfusion·1990
Heterogeneity in protein patterns of CGL blast crisis cells: discrimination between lymphatic and myeloic lineages.
Haematology and blood transfusion·1990
A Multimodal Graph Neural Network Based on MRI Radi-omics for Prognostic Prediction in Locally Advanced Cervical Squamous Cell Carcinoma.
Cancer control : journal of the Moffitt Cancer Center·2026
Outcomes That Matter in Gastrointestinal Cancer Care: A Focus Group Study of Patient-Centred Outcomes Identified by Patients and Care Partners.
Health expectations : an international journal of public participation in health care and health policy·2026
Nicotinamide Metabolism Constrains Memory CD8+ T Cell Formation Through a Putative HS1BP3-SIRT1-FOXO3-BCL6 Axis.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
GLP-1 receptor agonist therapy is associated with increased symptomatic remission in ulcerative colitis: a matched cohort study.
Inflammatory bowel diseases·2026
Modulating immune toxicity in ulcerative colitis using a small molecule RAB27A inhibitor.
Inflammatory bowel diseases·2026